key: cord-0720397-3i4g33ek authors: Scarpa, Alfonso; Di Stadio, Arianna; De Luca, Pietro; Calvanese, Matteo; Viola, Pasquale; Tassone, Domenico; de Campora, Luca; Simone, Matteo; Ricci, Giampietro; Messineo, Daniela; Ralli, Massimo; Cassandro, Claudia title: How can we manage Bezold abscess emergency in COVID-19 pandemic? Blind ceftriaxone and metronidazole treatment to avoid infection spread(†) date: 2021-10-26 journal: J Surg Case Rep DOI: 10.1093/jscr/rjab493 sha: 18ad4f5a02d26b811e25947eb72ffbd303ba149b doc_id: 720397 cord_uid: 3i4g33ek Bezold abscess (BA) can be a rare complication of different forms of otitis media. We describe a rare case of BA determined by Escherichia Coli. Because of COVID-19 restriction, the surgery had to be delayed up to the swab results. To avoid infection spread, the patient was treated by blind antibiotic treatment until the surgical drainage of mastoid and neck. Thanks to the treatment with broad-spectrum antibiotics, the progression and the spread of the infection during COVID-19 investigation was avoided. Delayed surgery could expose the patient to the risk of severe brain infection caused by the E. Coli. Bezold abscess (BA) can be a rare complication of acute, chronic or cholesteatomatous otitis media [1] ; the infection can be determined by several pathogens, e.g. Streptococcus [2] . Some of these pathogens can be more dangerous than others [2] and the infection has to be immediately treated to avoid risk of spreading in the surrounding tissues [1] [2] [3] [4] [5] [6] [7] [8] . † The study has been approved by the International Review Board of the hospital without release of ID in respect of law country for these types of studies. ‡ A. Scarpa and A. Di Stadio contributed equally to this article. Very few cases of BA have been described in the literature (Table 1 ) and, in none of these, the presence of Escherichia Coli in the BA was specifically found; E. Coli can be very harmful if not promptly and adequately treated and, especially during COVID-19 era, in which all surgical procedures are slightly delayed after the result of COVID-19 swab, the delay in treating the bacterial infection may expose patients to the risk of worsening the condition. Blind antibiotic treatment is generally discouraged due to the risk of resistance; however, in COVID-19 pandemic, blind combined antibiotic therapy could be necessary. We describe the management of a BA due to E. coli in a patient affected by cholesteatomatous chronic otitis media (CCOM) during the COVID-19 pandemic. A 17-year-old boy with cognitive-emotional impairment presented in August 2020, to our emergency department, complaining about the onset of a left-sided otalgia with purulent otorrhea, neck stiffness and pain on the ipsilateral side without fever. He had a history of bilateral CCOM for 8 years with recurrent flare-up, which was periodically treated by systemic antibiotic therapy and ear washing with acetic acid due to patient's refusal of surgery. The patient presented stiffness of the left side of the neck with hot and sweaty skin, associated with hyperemia and swelling in the left latero-cervical region. The inflammation affected the left mastoid region and extended caudally into the left supraclavicular fossa (Fig. 1A) . The otoscopic examination revealed bilateral perforation of the tympanic membrane and the presence of purulent discharge in the left ear (Fig. 1B) . Nasal endoscopy identified II grade adenoid hypertrophy with complete obliteration of left choanal opening and tubal ostium ( Fig. 2A and B) . A pure tone audiometry, performed only through bone conduction, showed bilaterally normal auditory threshold. Neck ultrasound identified the presence of abundant fluid in the left latero-cervical area, which extended from the retro-auricular region up to the ipsilateral supraclavicular area. Head and neck contrast-enhanced computed tomography (CT) scan confirmed the presence of the fluid below the left sternocleidomastoid muscle (Fig. 2C-E) with massive opacification of the mastoid cells and the middle ear (Fig. 3A) . Inflammatory tissue was identified in the middle ear with erosion of the ossicular bone chain (Fig. 3B) . A diagnosis of CCOM with BA was made. Intravenous therapy with ceftriaxone (2 g every 24 h), metronidazole (500 mg every 8 h), paracetamol (1 g every 8 h) and pantoprazole (40 mg every 24 h) was started because, due to COVID-19 restriction, it was not possible to immediately perform surgery before confirmation of negative COVID-19 swab. Once received the results of the COVID-19 test, we performed mastoidectomy, drainage of neck abscess (Fig. 1C) , adenoidectomy and inspection of middle ear. The purulent secretion was collected from external ear before starting surgery and then from the neck (Fig. 1 ) after a small incision of the skin and from middle ear during its inspection; all samples were sent to the microbiologist for culture and antibiogram. The inspection of the middle ear revealed the erosion of the ossicular chain without lateralization of the malleus, and presence of keratinizing squamous epithelium, confirming the CT findings. Escherichia coli was present in all three samples of the purulent secretion, and the antibiogram confirmed that the microbe was sensitive to the previously administered antibiotic therapy (ceftriaxone and metronidazole), although the dosage was insufficient to solve the infection. Due to the persistence of the infection after the 2 days of treatment, antibiotic therapy was changed increasing ceftriaxone (2 g/12 h) and metronidazole (500 mm/6 h). The treatment was continued for 7 days until patient discharge 10 days after admission. In October 2020, the patient underwent left tympanoplasty to remove the inflammatory tissue and cholesteatoma and to perform an ossiculoplasty. The last follow-up (January 2021) showed cleanness of the left external auditory canal, good results of tympanoplasty, normal bilateral auditory thresholds and clean neck area bilaterally. To the best of our knowledge, the case reports presented in the literature [1] [2] [3] [4] have never clearly described the presence of E. Coli as pathogen responsible of BA. Today, thanks to the use of antibiotics, BA has become a rare entity. The infection is generally caused by a series of microbes, which in the most of the cases, are easy treatable by a prompt antibiotic therapy. In fact, despite the fact that BA infections are often caused by polymicrobial flora, the Streptococcus pneumoniae is the most common microbe identified. Followed by less common pathogens, such as Pseudomonas aeruginosa, Klebsiella pneumoniae and Mycobacterium tuberculosis, and rare entities, such as Staphylococcus epidermidis and Proteus mirabilis [1] [2] [3] [4] [5] [6] [7] [8] . Unlike these pathogens, E. coli, which is commonly present in the gut and has immune-stimulating capacity [9] , can be very harmful because resistant to antimicrobial treatments. The delay of the surgery, due to the restrictions during COVID-19 pandemic, and the impossibility of the analysis of purulent secretion could expose the patient to severe risk of brain infection. An early treatment by broad-spectrum antibiotics, despite not being sufficient to solve the infection (dosage too low to eradicate E. Coli), was sufficient to avoid the progression of the infection until the surgical curettage of the BA. After surgery, the antibiotic treatment was properly modified to reach complete eradication of the pathogen without patient presented shortand long-term complication. COVID-19 pandemic is having an important impact on the management of many conditions, and the impact on the patients' health can be more relevant than expected. In the present case, the absence of an immediate surgical drainage of BA, associated with the incapacity of performing the analysis of purulent secretion in emergency, could transform a quite low-risk condition Contemporary presentation and management of a spectrum of mastoid abscesses Anaerobic mastoiditis: a report of two cases with complications Acute mastoiditis complicated with concomitant Bezold's abscess and lateral sinus thrombosis Bezold's abscess: a rare complication of suppurative mastoiditis A rare case of primary tuberculous otitis media with Bezold's abscess Complicated necrotizing otitis externa Bezold's abscess: a rare complication of acute otitis media Thorax necrotizing fasciitis following Bezold's abscess Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care None declared. This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.